Balyasny Asset Management LLC Meridian Bioscience Inc Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $229,170 - $245,650	7,357 New	7,357 $244,000
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $2.45 Million - $3.03 Million	-140,148 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.35 - $22.5 $2.16 Million - $2.81 Million	124,715 Added 808.11%	140,148 $2.7 Million
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $277,948 - $437,062	15,433 New	15,433 $342,000
Q3 2020 Nov 16, 2020	SELL	$13.54 - $26.41 $3.43 Million - $6.69 Million	-253,273 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $413,058 - $1.23 Million	52,686 Added 26.27%	253,273 $5.9 Million
Q1 2020 May 15, 2020	BUY	$5.57 - $11.5 $1.12 Million - $2.31 Million	200,587 New	200,587 $1.69 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.